呼吸机在胸外科肺癌术后患者中的运用体会  

Experience of the Ventilator-Supporting Therapy for Patients with Lung Cancer After Thoracic Surgery

作　　者：熊兰兰 宋颖 XIONG Lan-lan;SONG Ying(Department of Thoracic Surgery,Jiangxi Tumor Hospital,Jiangxi Nanchang 330017)

机构地区：[1]江西省肿瘤医院胸外科,江西南昌330017

出　　处：《中国医疗器械信息》2023年第13期123-125,共3页China Medical Device Information

摘　　要：目的:探讨呼吸机支持治疗在胸外科肺癌术后患者中的运用。方法:选取2019年12月~2020年11月本院胸外科收治的62例进行肺癌术患者作为研究对象,使用随机数字表法分为两组,各31例,对照组实施常规治疗,观察组在此基础上行呼吸机支持治疗,对比两组的肺功能指标、血气分析指标、并发症、舒适度情况。结果:观察组MVV、PE_(max)、MMF、PaCO_(2)、PaO_(2)均显著优于对照组(P<0.05);对照组的肺部感染、呼吸衰竭、肺水肿、心律失常发生率为19.4%,观察组的发生率为3.2%,观察组显著低于对照组(P<0.05);干预前,两组患者的Kolcaba评分比较无显著差异(P>0.05);干预后,两组患者的Kolcaba评分均有明显降低,且观察组显著低于对照组(P<0.05)。结论:呼吸机支持治疗在胸外科肺癌术后患者中的运用效果显著,能有效改善患者的肺功能指标和血气分析指标,减少并发症发生,提高舒适度,有利于促进患者康复。Objective:To explore the effects of the application of ventilator-supporting therapy to patients with lung cancer after thoracic surgery.Methods:62 cases of lung cancer patients admitted to the department of thoracic surgery of our hospital from December 2019 to November 2020 were selected as the research targets,and were divided into two groups(n=31)by random number table method.The control group received routine treatment,and the research group received ventilator-supporting treatment apart from the routine treatment.A comparison was made between the two groups in pulmonary function indexes,blood gas analysis indexes,occurrence of complications and comfort level of the patients.Results:Compared with the situation of the control group,the research group had a better performance in maximum ventilatory volume(MVV),maximum expiratory pressure(PEmax),maximum mid-expiratory flow rate(MMF),arterial partial pressure of carbon dioxide(PaCO2)and arterial partial pressure of oxygen(PaO2)(P<0.05).The incidence rates of pulmonary infection,respiratory failure,pulmonary edema and arrhythmia for the control group and the research group were 19.4%and 3.2%respectively,the observation group was significantly lower than the control group(P<0.05).Before intervention,there was no significant difference in Kolcaba scoring between the two groups(P>0.05);After intervention,the Kolcaba scoring for both of the two groups experienced significant decrease,and the Kolcaba scoring for the research group was significantly lower than that for the control group(P<0.05).Conclusion:The application of ventilator-supporting therapy to patients with lung cancer after thoracic surgery can achieve satisfactory efficacy,effectively improve the lung function index and blood gas analysis index of patients,reduce the occurrence of complications,improve comfort for patients,and can promote the recovery of patients.

关 键 词：胸外科 肺癌 呼吸机治疗 

分 类 号：R734.2[医药卫生—肿瘤]